Table 2 Baseline difference between responders and non-responders
Responders (n = 124) | Non-responders (n = 37) | P value | |
|---|---|---|---|
Age (years) | 66.7 ± 9.1 | 67.9 ± 10.5 | 0.51 |
Female (%) | 21.8 | 16.2 | 0.46 |
Ischemic cardiomyopathy (%) | 48.4 | 70.3 | 0.02 |
Atrial fibrillation (%) | 13.6 | 16.2 | 0.70 |
NYHA class | 3.1 ± 0.5 median 3 (IQR 3–3) | 3.2 ± 0.6 median 3 (IQR 3–4) | 0.52 |
Baseline LVEF (%) | 24.9 ± 5.1 median 25 (IQR 20–30) | 23.8 ± 5.3 median 23 (IQR 20–30) | 0.27 |
LVESD (mm) | 56.3 ± 8.2 | 60.1 ± 7.6 | 0.02 |
LVEDD (mm) | 65.7 ± 7.6 | 68.7 ± 7.0 | 0.04 |
Mitral regurgitation grade | 1.9 ± 1.1 median 2 (IQR 1–3) | 1.9 ± 1.1 median 2 (IQR 1–3) | 0.95 |
NT-proBNP (pg/ml) | 4284 ± 5862 median 2492 (IQR 1535–4800) | 4002 ± 4444 median 2700 (IQR 1898–4758) | 0.57 |
QRSd (ms) | 160 ± 20 | 147 ± 19 | 0.0006 |
QLV (ms) | 122.8 ± 25.7 | 98.2 ± 27.0 | 0.000002 |
QLV ratio | 0.76 ± 0.11 | 0.66 ± 0.14 | 0.000007 |